JAMA Health Forum Editors' Summary cover logo

New Evidence on the Effects of the COVID-19 Pandemic on Health Insurance Coverage

18m · JAMA Health Forum Editors' Summary · 03 Sep 15:00

We know that the pandemic caused millions of people to lose their jobs, and potentially their job-based insurance, and yet new survey data showed surprisingly small changes in uninsurance rates at the end of 2020. Kate Bundorf, PhD, from the Sanford School of Public Policy at Duke University and Jessica Banthin, PhD, of the Urban Institute talk to JAMA Health Forum Deputy Editor Melinda Buntin about these trends and the role played by Medicaid and exchange coverage. JAMA Health Forum Editor John Ayanian and Melinda Buntin also discuss other recent work about health insurance coverage and the ACA that has appeared in JAMA Health Forum.

Related Content:

  • Trends in US Health Insurance Coverage During the COVID-19 Pandemic
  • Fewer People May Have Become Uninsured in 2020 Than Feared
  • Outcomes After Changes to US Health Insurance Marketplace Automatic Renewal Rules
  • Income Eligibility for Medicaid vs Marketplace Coverage for Insurance Enrollment Among Low-Income Adults
  • Making the Affordable Care Act Marketplace More Affordable

The episode New Evidence on the Effects of the COVID-19 Pandemic on Health Insurance Coverage from the podcast JAMA Health Forum Editors' Summary has a duration of 18:27. It was first published 03 Sep 15:00. The cover art and the content belong to their respective owners.

More episodes from JAMA Health Forum Editors' Summary

Differences in Services Provided at Public and Nonprofit Hospitals Related to the 340B Drug Discount Program

JAMA Health Forum Editor John Ayanian, MD, MPP, speaks with Kelsey M. Owsley, PhD, of the University of Arkansas, and Sayeh Nikay, PhD, MPH, of the University of Minnesota, about how the 340B drug discount program influences the services offered by public and nonprofit hospitals. They also discuss new state policies and proposed federal policies to promote greater transparency and accountability in the 340B program.

Related Content:

  • US Hospital Service Availability and New 340B Program Participation
  • Public Hospitals May Use the 340B Program Differently Than Nonprofit Hospitals

Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy

Benjamin D. Sommers, MD, PhD, of Harvard University, speaks with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, about differences in Medicaid enrollment as measured in surveys and administrative data. These differences have implications for estimating coverage now that the federal policy of continuous Medicaid eligibility during the COVID-19 pandemic has ended.

Related Content:

  • Survey-Reported Coverage in 2019-2022 and Implications for Unwinding Medicaid Continuous Eligibility

Comparing Home Health Services in Traditional Medicare and Medicare Advantage

JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with Rachel A. Prusynski, DPT, PhD, of the University of Washington about differences in the use and outcomes of home health services provided to beneficiaries in traditional Medicare and Medicare Advantage.

Related Content:

  • Differences in Home Health Services and Outcomes Between Traditional Medicare and Medicare Advantage

Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic

The COVID-19 pandemic has caused major disruptions in ambulatory care. In this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses how access to care and preventive services changed for different racial and ethnic groups in the US from 2019 to 2022.

Related Content:

  • Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity

Opioid Prescription Duration Limits

JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with Lindsay D. Allen, PhD, about how setting-specific opioid prescription duration limits helped reduce opioid overuse in West Virginia.

Related Content:

  • Opioid Prescribing Patterns After Imposition of Setting-Specific Limits on Prescription Duration
Every Podcast » JAMA Health Forum Editors' Summary » New Evidence on the Effects of the COVID-19 Pandemic on Health Insurance Coverage